We have summarized in this review the role of PD-1/PD-L1 in the pathogenesis of IPF, and we still have a long way to go to translate these mechanisms into effective anti-pulmonary fibrosis therapies. This evidence concerns the gene CD274 and idiopathic pulmonary fibrosis.